Earningsreport

Q1/2020 6/30/2019 EPS -0.030 ZacksConsensus N/A ActVsEst N/A - N/A

IGC Pharma, Inc.  (IGC) 
NASDAQ:AMEX Investor Relations: igcinc.us/investor-center/overview